Background: Following international trends, the HPV (humanpapilloma virus) vaccine was introduced in Europe for protection against infection from common strands of the HPV virus which can lead to cervical cancer. Young women aged 18–26 years are at greatest risk of infection by the HPV virus yet have been neglected in research, policy, and practice. Purpose To explore young women's constructions of the HPV vaccine in four European countries with different implementation policies ranging from national school-basedprogrammes, regarded as the gold standard, to regional on demand and private provision.Method: Qualitative methods comprising 11 focus group discussions with 54 young women aged 18–26, in Scotland (n =10), Spain (n =25), Serbia (n =...
Objectives. We aimed to provide a detailed characterisation of human papillomavirus (HPV) vaccine aw...
BackgroundThe Scottish HPV vaccination programme serves youngwomen aged 11 to 18 years and reports c...
International audienceBACKGROUND: In France, it is recommended that girls and women aged 14-23 are v...
Background: Following international trends, the HPV (humanpapilloma virus) vaccine was introduced in...
Background: Cervical cancer remains one of the most prevalent cancers in the world. The HPV (Human P...
The Human Papilloma Virus (HPV) is the most common sexually transmitted infection (STI) and can caus...
Studies consistently identify poor levels of knowledge and awareness of Human Papillomavirus (HPV), ...
Background: Every year in Europe 60,000 women develop cervical cancer and 30,000 die from the diseas...
BACKGROUND: To identify the barriers and facilitators to uptake of the HPV vaccine in an ethnically ...
Cervical cancer occurs more often in under-screened women, and participation rates in cervical cance...
Objectives. We aimed to provide a detailed characterisation of human papillomavirus (HPV) vaccine aw...
BackgroundThe Scottish HPV vaccination programme serves youngwomen aged 11 to 18 years and reports c...
International audienceBACKGROUND: In France, it is recommended that girls and women aged 14-23 are v...
Background: Following international trends, the HPV (humanpapilloma virus) vaccine was introduced in...
Background: Cervical cancer remains one of the most prevalent cancers in the world. The HPV (Human P...
The Human Papilloma Virus (HPV) is the most common sexually transmitted infection (STI) and can caus...
Studies consistently identify poor levels of knowledge and awareness of Human Papillomavirus (HPV), ...
Background: Every year in Europe 60,000 women develop cervical cancer and 30,000 die from the diseas...
BACKGROUND: To identify the barriers and facilitators to uptake of the HPV vaccine in an ethnically ...
Cervical cancer occurs more often in under-screened women, and participation rates in cervical cance...
Objectives. We aimed to provide a detailed characterisation of human papillomavirus (HPV) vaccine aw...
BackgroundThe Scottish HPV vaccination programme serves youngwomen aged 11 to 18 years and reports c...
International audienceBACKGROUND: In France, it is recommended that girls and women aged 14-23 are v...